| Synonyms: | |
| Status: | Approved (2004) |
| Entry Type: | Antibody |
| Molecule Category: | UKNOWN |
| ATC: | L04AA23 |
| UNII: | 3JB47N2Q2P |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Integrin alpha-4/beta-1 inhibitor | DailyMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Multiple Sclerosis | 4 | D009103 | ClinicalTrials |
| Crohn Disease | 4 | D003424 | FDA |
| Multiple Sclerosis, Relapsing-Remitting | 3 | D020529 | ClinicalTrials |
| Multiple Sclerosis, Chronic Progressive | 3 | D020528 | ClinicalTrials |
| Multiple Sclerosis, Chronic Progressive | 3 | D020528 | ClinicalTrials |
| Arthritis, Rheumatoid | 2 | D001172 | ClinicalTrials |
| Graft vs Host Disease | 2 | D006086 | ClinicalTrials |
| Graft vs Host Disease | 2 | D006086 | ClinicalTrials |
| Ischemic Stroke | 2 | D000083242 | ClinicalTrials |
| Osteosarcoma | 1 | D012516 | ClinicalTrials |
| Schizophrenia | 1 | D012559 | ClinicalTrials |
| Myositis, Inclusion Body | 1 | D018979 | ClinicalTrials |
| Multiple Myeloma | 1 | D009101 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL1201607 |
| FDA SRS | 3JB47N2Q2P |
CONTENTS